Karuna Therapeutics Inc (KRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Sales | 654 | 10,637 | 36,964 | 0 | 0 |
| Gross Profit | 654 | 10,637 | 36,964 | N/A | N/A |
| Operating Expenses | 495,431 | 300,313 | 180,817 | 71,816 | 45,405 |
| Operating Income | -494,777 | -289,676 | -143,853 | -71,816 | -45,405 |
| Interest Expense | 0 | 0 | 0 | 0 | -11 |
| Other Income | 61,767 | 14,758 | 54 | 3,305 | 1,437 |
| Pre-tax Income | -433,010 | -274,918 | -143,799 | -68,511 | -43,957 |
| Income Tax | 670 | 1,418 | 6 | 43 | N/A |
| Net Income Continuous | -433,680 | -276,336 | -143,805 | -68,554 | -43,957 |
| Net Income | $-433,680 | $-276,336 | $-143,805 | $-68,554 | $-43,957 |
| EPS Basic Total Ops | -11.73 | -8.74 | -4.94 | -2.59 | -3.68 |
| EPS Basic Continuous Ops | -11.73 | -8.74 | -4.94 | -2.59 | -3.68 |
| EPS Diluted Total Ops | -11.73 | -8.74 | -4.94 | -2.59 | -3.68 |
| EPS Diluted Continuous Ops | -11.73 | -8.74 | -4.94 | -2.59 | -3.68 |
| EPS Diluted Before Non-Recurring Items | -11.73 | -8.74 | -4.94 | -2.59 | -3.68 |
| EBITDA(a) | $-531,042 | $-293,571 | $-142,284 | $-71,029 | $-45,226 |